Since its establishment in March 2022, the Creative Center Team (SQCCT) has organized activities and events to enhance employees’ internal communication. The goal is to provide them with a knowledge and skill-building experience that uplifts their competencies in the work environment, especially with recent graduates eager to contribute their scientific and life experiences and aspiring for broader opportunities for learning and contribution. Here are some highlights of what the team has accomplished during this period:
Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), a prominent figure in cancer care, has unveiled a groundbreaking advancement in the country: the Lutetium-177 (Lu-177) PSMA radionuclide therapy. This introduction expands its Theranostics Program, fundamentally reshaping the landscape of oncology treatment nationwide.
Gastrointestinal Cancers Program organized several scientific dialogue sessions under the name of (HBP café), which comes within the framework of exchanging medical knowledge and experiences in gastrointestinal cancers field, as the program hosts international experts from various health institutions and universities. The (HBP café) program began in 2022 and addressed rich and latest topics aiming to enhance the scientific competency of healthcare personals within Sultan Qaboos Comprehensive Cancer Care and Research Centre and beyond.
In a significant step towards innovative medical care, Gastrointestinal Cancers Program at Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) has performed the first Laparoscopic Radical Prostatectomy (LRP) in Oman.
LRP is a minimally invasive surgical procedure to remove the prostate gland in patients with prostate cancer.
The Radiology and Nuclear Medicine Department at Sultan Qaboos Comprehensive Cancer Center (SQCCCRC) represented by the Interventional Radiology Unit has successfully proven Diagnostic Reference Levels (DRLs) for Image-Guided Interventional Procedures (IGIPs), specifically for cancer patients in the Sultanate of Oman. This marks a significant step towards improving healthcare quality, ensuring the safety of patients and healthcare providers, and reducing unnecessary radiation exposure while keeping high-quality diagnostic and treatment procedures.
What do you know about hepatocellular carcinoma in Oman?
Approximately 60 cases of hepatocellular carcinoma (HCC) were detected in Oman in 2019, according to the latest statistics from the Ministry of Health, while the actual number is higher. Approximately 85% of HCC cases occurs in the presence of damaged liver parenchyma including chronic viral hepatitis B, fatty liver disease and liver cirrhosis which has many causes itself. While 15% of HCC cases occurs in normal liver.
Input your search keywords.